article thumbnail

Last Chance to Save on San Diego Life Sciences 2022

Xconomy

There’s just one week left before Xconomy’s latest biotech event, “San Diego Life Sciences 2022.” Next Monday, December 11, we’re taking an inside look at what the San Diego life sciences landscape will look like in the year 2022. Don’t let the clock run out while you can still save some cash on a ticket.

article thumbnail

Back to the (Near) Future: Join Us for San Diego Life Sciences 2022

Xconomy

In 2010, Xconomy convened “San Diego Life Sciences 2030,” a séance with the soothsayers of San Diego as they gazed into the future at what the local life sciences landscape might look like 20 years from now. Read more » Reprints | Share:

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

San Diego Life Sciences 2022: Photos and Takeaways

Xconomy

Nevertheless, Xconomy recently brought together some of San Diego’s most prominent life sciences leaders to offer their vision for what the regional biotech cluster will be like in five years. They broadly agreed that San Diego has proven itself as a great seedbed for life sciences startups. billion), CareFusion ($14.4

article thumbnail

Super Saver Rate Ending for San Diego Life Sciences 2022 on December 11

Xconomy

San Diego Biotech in 2030: A Center for Stem Cells, Genomics, Software, Neuroscience On December 11th, Mendlein will be reprising his role as. We get to peer into the future,” Mendlein said at the time. Everyone in this room is responsible for our collective future. It really is all in our hands.”

article thumbnail

Roche Trial of Ionis Huntington’s Disease Drug Halted After Side Effects

Xconomy

The suspension doesn’t appear to be related to the drug, tominersen, and no other trials of the investigational treatment were impacted—including an ongoing global Phase 3 study due to read out in 2022. The trial was likely paused to allow the pharma to reduce the amount of time the intrathecal catheters used for sampling.

Sample 120
article thumbnail

Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases

Xconomy

Dyne Therapeutics may not reach human testing until 2022, but, like many of its preclinical peers this year, the company is choosing to jump into public markets now while investor interest in the biotech sector is riding high.

Marketing 111
article thumbnail

After Successful Pilot, Apprenti Expands Tech Training Program

Xconomy

million new computer programming and computer support specialist jobs will be created across the country by 2022, and as businesses across all sectors become more tech-enabled and tech-dependent, that dearth of talent will only get worse. According to a forecast by the U.S. Bureau of Labor Statistics , more than 1.3